论文部分内容阅读
胃恶性淋巴瘤占胃恶性肿瘤的1～4%。通常,局限性恶性淋巴瘤采用外科疗法和放射疗法,全身性恶性淋巴瘤采用化学疗法。胃恶性淋巴瘤的外科疗法是施行胃切除术和淋巴结清除术。治疗前,首先要进行扁桃体和浅表淋巴结的触诊,Ga-闪烁摄影、CT 及超声波检查,弄清病变范围。Ⅰ、Ⅱ期采用外科疗法;Ⅱ期病例术后,应进行1～2疗程的联合化疗;Ⅲ期病例施行根治术后,多进行联合化疗。Ⅲ、Ⅳ期不适宜手术的病例应施行强力化疗。胃恶性淋巴瘤多属于非何杰金氏型。在组织学上70～80%为组织细胞弥散型。一般认为化学疗法是可行的。而且,必须联合用药。目前标准的化疗方案是包括环磷酰胺(CTX)、阿霉素(ADM)、长春新硷
Gastric malignant lymphomas account for 1 to 4% of gastric malignancies. In general, localized malignant lymphoma adopts surgical therapy and radiation therapy, and systemic malignant lymphoma adopts chemotherapy. Surgical treatment of gastric malignant lymphomas is performed with gastrectomy and lymphadenectomy. Before treatment, palpation of the tonsils and superficial lymph nodes should be performed first, Ga-scintillation photography, CT, and ultrasound examination should be performed to clarify the extent of the lesion. Stage I and II use surgical therapy; in stage II cases, 1 to 2 courses of combination chemotherapy should be performed; in stage III cases, radical surgery should be followed by multiple combination chemotherapy. Cases III and IV not suitable for surgery should be treated with strong chemotherapy. Gastric lymphomas are mostly non-Hodgkin’s. In histology, 70 to 80% are diffused in tissue cells. It is generally believed that chemotherapy is feasible. Moreover, medication must be used in combination. Current standard chemotherapy regimens include cyclophosphamide (CTX), adriamycin (ADM), and Changchun Xinjing.